A detailed history of Ossiam transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ossiam holds 7,975 shares of RPRX stock, worth $200,332. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,975
Previous 6,926 15.15%
Holding current value
$200,332
Previous $182,000 23.63%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.63 - $29.27 $26,885 - $30,704
1,049 Added 15.15%
7,975 $225,000
Q2 2024

Aug 13, 2024

BUY
$26.26 - $29.9 $6,249 - $7,116
238 Added 3.56%
6,926 $182,000
Q1 2024

May 13, 2024

SELL
$27.46 - $31.33 $139,606 - $159,281
-5,084 Reduced 43.19%
6,688 $203,000
Q3 2023

Nov 14, 2023

BUY
$26.26 - $31.38 $134,214 - $160,383
5,111 Added 76.73%
11,772 $319,000
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $88,800 - $109,680
3,000 Added 81.94%
6,661 $204,000
Q1 2023

May 12, 2023

BUY
$32.77 - $39.4 $21,890 - $26,319
668 Added 22.32%
3,661 $131,000
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $119,360 - $133,637
2,993 New
2,993 $120,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Ossiam Portfolio

Follow Ossiam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.